| 专论编号 | 物质名称 | 证书持有人 | 持有人ORG-ID和LOC-ID | 证书编号 | 发布日期 | 证书状态 | 到期续期 | 证书结束日期 | 证书类型 | 上一程序的结束日期 | 历史数据 程序类型|结论|日期 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2423 | Valsartan, Process II | MATRIX PHARMACORP PRIVATE LIMITED Sangareddy District IN | 100051463;100098142 | CEP 2024-007 - Rev 02 | 2025/10/07 | Valid | 12/06/2029 | Chemical | 2025/10/07 | Notification|CEP granted|07/10/2025; Notification|CEP granted|26/07/2024; New application|CEP granted|12/06/2024 |
|
| 1705 | Sertraline hydrochloride, Process-II | MATRIX PHARMACORP PRIVATE LIMITED Sangareddy District IN | 100051463;100098142 | CEP 2023-151 - Rev 04 | 2025/10/07 | Valid | 12/07/2028 | Chemical | 2025/10/07 | Notification|CEP granted|07/10/2025; Minor revision|CEP granted|08/07/2025; Administrative procedure|CEP granted|01/08/2024; Notification|CEP granted|25/07/2024; New application|CEP granted|12/07/2023 |
|
| 2270 | Sildenafil citrate | MATRIX PHARMACORP PRIVATE LIMITED Sangareddy District IN | 100051463;100098142 | CEP 2012-317 - Rev 03 | 2025/10/07 | Valid | Chemical | 2025/10/07 | Notification|CEP granted|07/10/2025; Minor revision|CEP granted|05/03/2025; Notification|CEP granted|25/07/2024 |
||
| 2857 | Trazodone hydrochloride | MATRIX PHARMACORP PRIVATE LIMITED Sangareddy District IN | 100051463;100098142 | CEP 2023-159 - Rev 01 | 2025/10/07 | Valid | 08/08/2029 | Chemical | 2025/10/07 | Notification|CEP granted|07/10/2025; Minor revision|Accepted - CEP remains valid|17/04/2025; New application|CEP granted|08/08/2024 |
|
| 2423 | Valsartan, Process III | MATRIX PHARMACORP PRIVATE LIMITED Sangareddy District IN | 100051463;100098142 | CEP 2024-113 - Rev 02 | 2025/10/07 | Valid | 14/06/2029 | Chemical | 2025/10/07 | Notification|CEP granted|07/10/2025; Notification|CEP granted|25/07/2024; New application|CEP granted|14/06/2024 |
|
| 796 | Valine | SHANGHAI PLUMINO AMINO ACID CO., LTD. Shanghai CN | 100025187;100034386 | CEP 2007-364 - Rev 02 | 2025/10/06 | Valid | Chemical | 2025/10/06 | Notification|CEP granted|06/10/2025; Notification|Accepted - CEP remains valid|07/05/2024; Minor revision|Accepted - CEP remains valid|22/11/2022 |
||
| 770 | Isoleucine | SHANGHAI PLUMINO AMINO ACID CO., LTD. Shanghai CN | 100025187;100034386 | CEP 2010-188 - Rev 01 | 2025/10/06 | Valid | Chemical | 2025/10/06 | Notification|CEP granted|06/10/2025; Minor revision|Accepted - CEP remains valid|18/11/2024; Minor revision|Accepted - CEP remains valid|07/06/2024; Minor revision|Accepted - CEP remains valid|20/03/2023 |
||
| 910 | Histidine Hydrochloride Monohydrate | SHANGHAI PLUMINO AMINO ACID CO., LTD. Shanghai CN | 100025187;100034386 | CEP 2010-047 - Rev 02 | 2025/10/06 | Valid | Chemical | 2025/10/06 | Notification|CEP granted|06/10/2025; Minor revision|Accepted - CEP remains valid|07/06/2024; Minor revision|Accepted - CEP remains valid|03/09/2021 |
||
| 752 | Alanine | SHANGHAI PLUMINO AMINO ACID CO., LTD. Shanghai CN | 100025187;100034386 | CEP 2007-351 - Rev 02 | 2025/10/06 | Valid | Chemical | 2025/10/06 | Notification|CEP granted|06/10/2025; Notification|Accepted - CEP remains valid|06/05/2024; Minor revision|Accepted - CEP remains valid|11/08/2023; Major revision|CEP granted|12/01/2023; Major revision|Rejected|17/09/2021 |
||
| 803 | Amiodarone hydrochloride | AREVIPHARMA GMBH Radebeul DE | 100011616;100022155 | CEP 2005-225 - Rev 04 | 2025/10/06 | Valid | Chemical | 2025/10/06 | Administrative procedure|CEP granted|06/10/2025; Monograph revision|Accepted - CEP remains valid|22/09/2025; Minor revision|CEP granted|11/03/2024; Notification|Accepted - CEP remains valid|23/01/2020 |
||
| 1072 | Betaxolol hydrochloride | FDC Limited Mumbai IN | 100011646;100021030 | CEP 2022-334 - Rev 01 | 2025/10/06 | Valid | 08/02/2029 | Chemical | 2025/10/06 | Minor revision|CEP granted|06/10/2025; New application|CEP granted|08/02/2024 |
|
| 2372 | Esomeprazole magnesium trihydrate, ESQ process | MATRIX PHARMACORP PRIVATE LIMITED Sangareddy District IN | 100051463;100098142 | CEP 2023-164 - Rev 02 | 2025/10/06 | Valid | 23/06/2028 | Chemical | 2025/10/06 | Notification|CEP granted|06/10/2025; Notification|CEP granted|29/07/2024; New application|CEP granted|23/06/2023 |
|
| 1734 | Terbinafine hydrochloride, Process 2, Micronised, non-micronised | SHANDONG ANHONG PHARMACEUTICAL CO., LTD. Dezhou CN | 100014777;100050265 | CEP 2024-501 - Rev 01 | 2025/10/06 | Valid | 22/01/2030 | Chemical | 2025/10/06 | Minor revision|CEP granted|06/10/2025; New application|CEP granted|22/01/2025 |
|
| 1292 | Amphotericin B, Process II, for use in the manufacture of parenteral preparations | ZHEJIANG TIANTAI PHARMACEUTICAL CO., LTD. Taizhou City CN | 100011852;100018559 | CEP 2023-152 - Rev 01 | 2025/10/06 | Valid | 03/07/2029 | Chemical | 2025/10/06 | Minor revision|CEP granted|06/10/2025; New application|CEP granted|03/07/2024 |
|
| 2192 | Atovaquone | IPCA LABORATORIES LIMITED Mumbai IN | 100011685;100018680 | CEP 2021-107 - Rev 02 | 2025/10/06 | Valid | 21/01/2027 | Chemical | 2025/10/06 | Administrative procedure|CEP granted|06/10/2025; Minor revision|CEP granted|24/09/2025; Notification|Accepted - CEP remains valid|23/06/2023; New application|CEP granted|21/01/2022 |
|
| 2579 | Saw palmetto extract, DER : 10-14.3:1 - Extraction solvent : Ethanol 90% m/m | EUROMED S.A. Mollet del Vallès ES | 100014852;100023498 | CEP 2020-238 - Rev 02 | 2025/10/03 | Valid | Herbal | 2025/12/03 | Notification|Accepted - CEP remains valid|03/12/2025; Renewal|CEP granted|03/10/2025; Monograph revision|Accepted - CEP remains valid|13/08/2024; Minor revision|CEP granted|21/01/2021; New application|CEP granted|05/11/2020 |
||
| 2338 | Mirtazapine | MICRO LABS LIMITED Bengaluru IN | 100017819;100077269 | CEP 2025-182 - Rev 00 | 2025/10/03 | Valid | 03/10/2030 | Chemical | 2025/10/03 | New application|CEP granted|03/10/2025 | |
| 797 | Aspartic Acid | WUHAN GRAND HOYO CO., LTD. Wuhan CN | 100023371;100090500 | CEP 2025-134 - Rev 00 | 2025/10/03 | Valid | 03/10/2030 | Chemical | 2025/10/03 | New application|CEP granted|03/10/2025 | |
| 2583 | Montelukast sodium | MATRIX PHARMACORP PRIVATE LIMITED Sangareddy District IN | 100051463;100098142 | CEP 2011-245 - Rev 04 | 2025/10/03 | Valid | Chemical | 2025/10/03 | Administrative procedure|CEP granted|03/10/2025; Notification|CEP granted|15/09/2025; Monograph revision|Accepted - CEP remains valid|27/03/2025; Major revision|CEP granted|18/09/2024; Notification|CEP granted|01/09/2021 |
||
| 227 | Lidocaine hydrochloride monohydrate | APEX HEALTHCARE LIMITED Ankleshwar IN | 100039365;100061975 | CEP 2024-258 - Rev 00 | 2025/10/02 | Valid | 02/10/2030 | Chemical | 2025/10/02 | New application|CEP granted|02/10/2025 |
请输入需要查询的英文物质名称,证书持有人,证书编号,专论编号